On this page
Back to topMiniMed Group MMED
MiniMed Group listed on Nasdaq on 6 Mar 2026 and is not in the S&P 500. It is worth $4.6 billion. Its price history starts on 6 Mar 2026. Its board has 11 directors, 5 of them independent. 5 other officers are on file. At 30 Jun 2026, MFS (Massachusetts Financial Services) was its largest institutional holder, with 3.0% of the company.
- CEO
- Que Dallara
- Chair
- Kevin E. Lofton
- Listed
- 6 Mar 2026 on Nasdaq, IPO filings and terms
- Headquarters
- Northridge, CA
- Market cap
- $4.6B
- 19 Nov 2026 close
- Price to sales
- 1.5
- Market cap over revenue
Financials
Financial history
Twelve months to 31 Jul 2026, from MiniMed Group's quarterly filings.
Quarters since Jan 2025
- P/E
- -
- No profit over the last four quarters
Quarterly results
Each quarter's revenue, net income and free cash flow.
Jan 2025 to Jul 2026
| Quarter | Revenue | Net income |
|---|---|---|
| Jul 2026 | $843M | $0 |
| Apr 2026 | $837M | $-193M |
| Jan 2026 | $790M | $-119M |
| Jul 2025 | $723M | $-16M |
| Apr 2025 | $724M | $-179M |
| Jan 2025 | $687M | $-10M |
Revenue breakdown
MiniMed Group's $843M of revenue, as its quarterly report splits it. Parts that are not a business, such as sales between segments, can be negative.
Quarter to Jul 2026
| Split by | Part | Revenue |
|---|---|---|
| Product | CGM | $431M |
| Product | Consumables | $261M |
| Product | Pumps | $144M |
| Product | Other | $7M |
| Region | International | $603M |
| Region | UNITED STATES | $240M |
MiniMed Group's market cap since March 2026
Weekly, up to 13 Nov 2026
| Week ending | Market cap |
|---|---|
| 13 Nov 2026 | $5.1B |
Download MiniMed Group's data as JSON, with the weekly market caps in billions of dollars from 6 Mar 2026.
Board and leadership
Board and officers
2 people here also hold roles at other S&P 500 companies.
Board from the proxy filed 21 Aug 2026; officers filed up to 30 Sep 2026
| Name | Title | Since | Independent | Committees | Age |
|---|---|---|---|---|---|
| Directors (11) | |||||
| Kevin E. LoftonChairIndependent 路 since 2026 路 Compensation and Talent, Nominating and Corporate Governance (chair)Former Chief Executive Officer, CommonSpirit HealthAlso at Medtronic | |||||
| Que DallaraChief Executive OfficerNot independent 路 since 2026Other boards: Lattice Semiconductor | |||||
| Linnea BurmanDirectorNot independent 路 since 2026Senior Vice President and President, Neurovascular, Medtronic plc | |||||
| Scott T. CundyDirectorNot independent 路 since 2026 路 Nominating and Corporate GovernanceSenior Vice President and Chief Quality, Development, and Innovation Officer, Medtronic plc | |||||
| Glenn A. EisenbergDirectorIndependent 路 since 2026 路 Audit (chair)Special Advisor to Labcorp; Senior Advisor at Rh么ne Group; Former Executive Vice President and Chief Financial Officer, Labcorp Holdings Inc.Also at SolventumOther boards: Lumexa Imaging Holdings and The Middleby Corporation | |||||
| David J. EndicottDirectorIndependent 路 since 2026 路 Compensation and TalentChief Executive Officer, Alcon, Inc.Other boards: Alcon | |||||
| D. Keith GrossmanDirectorIndependent 路 since 2026 路 Audit, Nominating and Corporate GovernanceFormer Chair and Chief Executive Officer, Nevro Corp.Other boards: Outset Medical and Alcon | |||||
| Robert (Bob) HopkinsDirectorNot independent 路 since 2026 路 Nominating and Corporate GovernanceSenior Vice President and Head of Global Strategy, Medtronic plc | |||||
| Laura MauriDirectorNot independent 路 since 2026 路 Compensation and TalentSenior Vice President, Chief Scientific and Medical Officer, Medtronic plc | |||||
| Matthew (Matt) R. WalterDirectorNot independent 路 since 2026 路 Compensation and TalentSenior Vice President of Human Resources, IT and Global Communications and Corporate Marketing, Medtronic plc | |||||
| Timothy A. WicksDirectorIndependent 路 since 2026 路 Audit, Compensation and Talent (chair)Former Chief Executive Officer and President, OptumRXOther boards: BrightSpring Health Services and GMR Solutions | |||||
| Officers (5) | |||||
| Chad SpoonerEVP, Chief Financial OfficerLast filed 29 Jul 2026 | |||||
| Gillian ChandrasenaSVP, Chief HR OfficerLast filed 29 Jul 2026 | |||||
| Ali DianatyEVP Ch. Prod. & Tech OfficerLast filed 4 Aug 2026 | |||||
| Christopher EsoPresidentLast filed 5 Mar 2026 | |||||
| John GyurciVP, Chief Accounting OfficerLast filed 6 Jul 2026 | |||||
Owners and trading
Largest institutional holders
Each fund group's share of MiniMed Group. Where a company has several share classes, the share is of its total value.
13F filings for the quarter to 30 Jun 2026
Timeline
Leadership changes, layoffs and insider sales
20 Nov 2024 to 20 Nov 2026; insider sales from 19 Nov 2025
7 departures and 19 appointments of directors and officers in the last two years.
Events, newest first
- 15 Oct 2026 Matthew R. Walter resignedDirector
- 15 Oct 2026 Laura Mauri resignedDirector
- 15 Oct 2026 Scott Cundy resignedDirector
- 15 Oct 2026 Linnea Burman resignedDirector
- 15 Oct 2026 Amy Bricker appointedDirector
- 30 Jul 2026 Courtney Nelson Wills resignedSenior Vice President, General Counsel and Corporate Secretary, effective 25 Sep 2026
- 25 Jun 2026 Linnea Burman appointedDirector, effective 29 Jun 2026
- 25 Jun 2026 David Endicott appointedDirector, effective 29 Jun 2026
Showing 8 of 26 events
| Date | Event | Filing |
|---|---|---|
| 15 Oct 2026 | Matthew R. Walter resignedDirector | 8-K |
| 15 Oct 2026 | Laura Mauri resignedDirector | 8-K |
| 15 Oct 2026 | Scott Cundy resignedDirector | 8-K |
| 15 Oct 2026 | Linnea Burman resignedDirector | 8-K |
| 15 Oct 2026 | Amy Bricker appointedDirector | 8-K |
| 30 Jul 2026 | Courtney Nelson Wills resignedSenior Vice President, General Counsel and Corporate Secretary, effective 25 Sep 2026 | 8-K |
| 25 Jun 2026 | Linnea Burman appointedDirector, effective 29 Jun 2026 | 8-K |
| 25 Jun 2026 | David Endicott appointedDirector, effective 29 Jun 2026 | 8-K |
| 17 May 2026 | Brett Wall resignedClass II director, effective 3 Jul 2026 | 8-K |
| 17 May 2026 | Scott Cundy appointedDirector, effective 3 Jul 2026 | 8-K |
| 5 Mar 2026 | Brian Sandstrom resignedDirector, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | John Gyurci appointedVice President, Chief Accounting Officer and Controller, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Gillian Chandrasena appointedSenior Vice President, Chief Human Resources Officer, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Courtney Nelson Wills appointedSenior Vice President, General Counsel, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Ali Dianaty appointedExecutive Vice President, Chief Product & Technology Officer, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Chad Spooner appointedExecutive Vice President & Chief Financial Officer, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Que Dallara appointedChief Executive Officer, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Timothy (Tim) A. Wicks appointedMember of the Board, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Matthew (Matt) R. Walter appointedMember of the Board, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Brett A. Wall appointedMember of the Board, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Laura Mauri appointedMember of the Board, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Robert (Bob) A. Hopkins appointedMember of the Board, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | D. Keith Grossman appointedMember of the Board, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Glenn Eisenberg appointedMember of the Board, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Que Dallara appointedMember of the Board, effective 6 Mar 2026 | 8-K |
| 5 Mar 2026 | Kevin E. Lofton appointedChair of the Board, effective 6 Mar 2026 | 8-K |
Not on file: no open-market insider buys or sales in the 12 months to 19 Nov 2026, no trades disclosed by members of Congress or officials since November 2023, no WARN layoff notices under its own name or a listed subsidiary's since November 2023, no open roles from its careers site yet and no earnings release figures from the last six months.